- Home
- KMDA vs GLRE Comparison
KMDA vs GLRE Comparison
Compare KMDA & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KMDA | GLRE |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | Israel | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 488.6M | 481.5M |
| IPO Year | 2013 | 2007 |
Fundamental Metrics
Financial Performance| Metric | KMDA | GLRE |
|---|---|---|
| Price | $8.44 | $17.92 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | 62.8K | ★ 260.3K |
| Earning Date | 05-13-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | N/A | ★ 75.00 |
| EPS | N/A | ★ 2.17 |
| Revenue | N/A | ★ $729,777,000.00 |
| Revenue This Year | $13.94 | N/A |
| Revenue Next Year | $9.84 | N/A |
| P/E Ratio | $24.59 | ★ $8.51 |
| Revenue Growth | N/A | ★ 4.85 |
| 52 Week Low | $6.24 | $11.57 |
| 52 Week High | $9.35 | $18.99 |
Technical Indicators
Market Signals| Indicator | KMDA | GLRE |
|---|---|---|
| Relative Strength Index (RSI) | 49.22 | 64.57 |
| Support Level | $8.38 | $12.49 |
| Resistance Level | $8.88 | N/A |
| Average True Range (ATR) | 0.19 | 0.53 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 74.60 | 62.77 |
Price Performance
Historical ComparisonAbout KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.